PitchBook · Jul 2026
PitchBook shows historical funding activity including accelerator/incubator participation, grants, and seed rounds, with a latest deal amount listed at $250K.
XGenomes is building the sequencing technology of the future.
Company research
Public company, workplace, funding, and market signals
Overview
XGenomes is a Cambridge-based biotechnology company developing a next-generation DNA sequencing platform that combines novel biochemistry, hardware, and AI to detect molecular signals of health, disease, and aging. Its mission is to make multi-omic information accessible throughout life, supporting health baselines, early disease detection, and intervention monitoring.
Primary product
OneBox sequencing system / sample-to-sequence platform
Founded
2017
Headquarters
Cambridge, Massachusetts, United States
Team size
1-10
Work style
Onsite
Industry
Biotechnology Research
Sub-industry
DNA sequencing / genomics tools
Offices
Open Positions
0 jobs at XGenomes
No open positions
Check back later for new openings